Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis

Roberta Magliozzi1,2, Owain W Howell3,4, Massimiliano Calabrese3

  • 1Neurology Section of Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy. roberta.magliozzi@univr.it.

PubMed

Insights

The meninges, or brain membranes, play a crucial role in multiple sclerosis (MS) inflammation and neurodegeneration. Targeting meningeal inflammation offers a promising therapeutic strategy for progressive MS.

Area of Science:

  • Neuroimmunology
  • Neuropathology

Background:

  • The meninges are increasingly recognized for their role in the inflammatory and neurodegenerative processes of progressive multiple sclerosis (MS).
  • The subarachnoid and perivascular spaces within the meninges facilitate immune cell entry and inflammatory molecule diffusion into the brain parenchyma.
  • Meningeal spaces also serve as a route for the egress of central nervous system (CNS)-derived components.

Purpose of the Study:

  • To review and discuss the cellular, molecular, and radiological evidence implicating meningeal inflammation in MS pathogenesis.
  • To explore the clinical and therapeutic implications of meningeal inflammation in MS.

Main Methods:

  • Review of existing literature on cellular, molecular, and radiological findings related to meningeal inflammation in MS.
  • Analysis of cerebrospinal fluid and post-mortem brain tissue studies in MS patients and animal models.

Main Results:

  • Chronic meningeal inflammation is associated with a more severe clinical course in MS.
  • Immune cell aggregates in the meninges are implicated in MS pathology.
  • Understanding meningeal compartmentalization of inflammation is vital for therapeutic development.

Conclusions:

  • The meninges are a critical site for immune activity in MS.
  • Targeting meningeal inflammation represents a potential therapeutic avenue for progressive MS.
  • Further research into the precise mechanisms of meningeal involvement in MS is warranted.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...